Enzymatic Release of Fucose

Enzymatic Release of Fucose

Fucose is released from fucose-containing polymers by an enzyme found in lysosomes called α-fucosidase. CD BioGlyco has advanced Enzymatic Release methods to provide clients with high-quality fucose release services.

Overview of Fucose

Fucose is a deoxyhexose sugar with the chemical formula C6H12O5, which is present in a variety of glycoproteins and glycolipids produced by insects, plant cells, and mammals. In mammals, fucose-containing glycans play important roles in transfusion responses, host-microbe interactions, selectin-mediated leukocyte-endothelial adhesion, and many ontogenic events. Fucosylation is the transfer of fucose residues from guanosine diphosphate (GDP)-fucose donor to an acceptor molecule and is part of the ABO blood group and Lewis antigen systems. According to the different fucose addition sites, fucosylation is divided into α1-2-, α1-3/4-, α1-6-, and O-fucosylation. In humans, fucosylation is carried out by a group of 13 enzymes, each showing a specific activity.

The potential applications of fucose are becoming increasingly apparent in the fields of medicine and dietary supplements. In immunoglobulins, fucosylation of antibodies has been established to reduce binding to Fc receptors on natural killer cells, thereby reducing antibody-dependent cell-mediated cytotoxicity (ADCC). Therefore, fucosylated monoclonal antibodies have been designed to recruit the immune system to cancer cells and have been made in cell lines lacking the core fucosylase (FUT8), thereby enhancing cell killing in vivo.

Fucose Release Service

Enzymes are useful for the structural analysis of glycans and polysaccharides and for establishing structure-activity relationships in biological systems. Due to the biological importance of fucose, it is highly necessary to develop a systematic strategy to release fucose from protein. At CD BioGlyco, we have developed a Glycan Release platform to provide clients with efficient and accurate fucose release services. Fucosidase is a unique tool for hydrolyzing fucose on proteins. Under the action of fucosidase, we efficiently release α1-2, α1-3, and α1-4 linked fucose present on N-glycosylated proteins, O-glycosylated proteins, or free oligosaccharides.

Fig.1 The process of enzymatic release of fucose.Fig.1 The process of enzymatic release of fucose. (CD BioGlyco)

Applications

  • Defucosylation of native glycoproteins
  • Research of biological functions of fucose in mammals
  • Research of chemistry and biochemistry of D- and L-fucose
  • Study of the relationship between fucose and diseases

Advantages of Us

  • Release of fucose on N-glycosylated proteins, O-glycosylated proteins, or free oligosaccharides
  • Release α1-2, α1-3, and α1-4 linked fucose
  • Efficient and accurate
  • Professional technical team

CD BioGlyco not only provides a systematic experimental platform and advanced technical approaches; but also provides flexible guidance to help clients complete their scientific research work in a timely and efficient manner. If you are interested in our fucose release services, please contact us for more detailed information.

References:

  1. Roca, C.; et al. Exopolysaccharides enriched in rare sugars: bacterial sources, production, and applications. Frontiers in microbiology. 2015, 10(6): 288.
  2. Yu, X.; et al. Improving antibody-based cancer therapeutics through glycan engineering. BioDrugs. 2017, 31(3): 151-166.
This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.